I-Infesucious ye-HIV hcv hshlog kunye ne-syphilid ngokukhawuleza
Ulwazi lwemveliso
| Inombolo yemodeli | Hbsag / tp & HIV / hcv | Ukupakisha | Iimvavanyo ezingama-20 / ikhithi, i-30Kits / ctn |
| Igama | I-HBSAG / TP & HIV / HCV Phiciation Comm | Ukuhlelwa kwesixhobo | Iklasi i-III |
| Iimbonakalo | Imvakalelo ephezulu, ukusebenza ngokulula | Isatifiketi | I-CE / ISO13485 |
| Ukuchaneka | > I-97% | Beka ubomi kwishelufa | Iminyaka emibini |
| Indlela yokusebenza | IGolloidal igolide | Inkonzo ye-OEM / ODM | I-avaudiod |
Ukuphakama
Ixesha lovavanyo: I-15-20mins
Ukugcinwa: 2-30 ℃ / 36-86 ℉
Indlela yokusebenza: Igolide yeColodal
Inqaku:
• enobuthathaka obuphezulu
• Iziphumo zokufunda kwimizuzu eli-15 ukuya kwengama-20
Ukusebenza ngokulula
• Ukuchaneka okuphakathi
Ukusetyenziswa kwenjongo
Le khit ilungele ukumiselwa kwe-vitro onemgangatho we-hepatitis b intsholongwane, i-syphilis spirochete, intsholongwane ye-smfordeficcys, kunye ne-hepatitis c intsholongwane kwi-serum yomntu / i-PLAUSI-ma / igazi liphela legazi lokuxilongwa kwe-hepatitis b rirus, iSyphilis Spirochete, intsholongwane ye-hepatiticcy, kunye nesifo se-hepatitic. Iziphumo ezifunyenweyo kufunekahlaziywa ngokudibeneyo nolunye ulwazi lweklinikhi. Yenzelwe ukusetyenziswa ngabasebenzi bezonyango kuphela.
Inkqubo yovavanyo
| 1 | Funda umyalelo wokusetyenziswa kunye nokungqinelana ngokungqongqo ngokufundisa okusetyenziselwa ukusebenza okufunekayo ukunqanda okuchaphazela ukuchaneka kweziphumo zovavanyo |
| 2 | Phambi kovavanyo, ikhithi kunye nesampulu zikhutshwa kwimo yokumsindo kwaye zilungelelaniswe kubushushu begumbi kwaye ziphawule. |
| 3 | Ukukrazula ukupakishwa kwengxowa ye-aluminium, khupha isixhobo kwaye siphawule, emva koko sibeke ngokuthe tyaba kwitafile yovavanyo. |
| 4 | Iisampulu ze-ipium / iisampulu zeplasma ezinamachaphaza amalala kwaye zongeza amaconsi ama-2 kwiqula nganye ye-S1 ne-S2; Yongeza amaconsi ama-3 kwiqula nganye ye-S1 kunye ne-S2 ngeesampulu zonke zegazi ngaphambi kongeza isisombululo se-1 ~ 2 secomp yesisombululo se-rinse kwi-quels s1 kunye nexesha lokuqalwa kwexesha |
| 5 | Iziphumo zovavanyo kufuneka zitolikwe ngaphakathi kwe-15 ~ 20 imizuzu, ukuba ngaphezulu kwe-20 yemizuzu yeziphumo azisebenzi. |
| 6 | Ingcaciso ebonakalayo inokusetyenziswa ngenxa yokutolikwa. |
Qaphela: Isampulu nganye iya kufakwa kumbhobho wokuhlanjwa okucocekileyo ukunqanda ungcoliseko lomnqamlezo.
Umsebenzi weKlinikhi
| Iziphumo ze-WizHbsag
| Uvavanyo lwesiphumo sokurenta kwakhona | Ireyithi efanelekileyo yokuhlangana: 99.06% (95% CI 96.64% ~ 99.74%) Ixabiso elibi lokulinganisa: 98.69% (95% CI96.68% ~ 99.49%) Ixabiso elipheleleyo lezinto zokulinganisa: 98.84% (95% CI97.50% ~ 99.47% | ||
| Ikhanyanisi | Engalunganga | Iyonke | ||
| Iposti | 211 | 4 | 215 | |
| Engalunganga | 2 | 301 | 303 | |
| Iyonke | 213 | 305 | I-518 | |
| Iziphumo ze-WizTP
| Uvavanyo lwesiphumo sokurenta kwakhona | Ixabiso eliqinisekileyo lokulinganisa: 96.18% (I-95% CI 91.38% ~ 98.36%) Ixabiso elibi elingalunganga: 97.67% (95% CI95.64% ~ 98.77%) Inani elipheleleyo lemithombo yobuchule: 97.30% (95% CI95.51% ~ 98.38%) | ||
| Ikhanyanisi | Engalunganga | Iyonke | ||
| Iposti | 126 | 9 | 135 | |
| Engalunganga | 5 | 378 | 383 | |
| Iyonke | 131 | 387 | I-518 | |
| Iziphumo ze-WizHcv
| Uvavanyo lwesiphumo sokurenta kwakhona | Ireyithi efanelekileyo yokuhlangana: 93.44% (95% CI 84.32% ~ 97.42%) Ixabiso elibi lokuhlangana: 99.56% (95% CI98.42% ~ 99.88%) Ixabiso elipheleleyo lezinto zokulinganisa: 98.84% (95% CI97.50% ~ 99.47%) | ||
| Ikhanyanisi | Engalunganga | Iyonke | ||
| Iposti | 57 | 2 | 59 | |
| Engalunganga | 4 | 455 | 459 | |
| Iyonke | I-61 | 457 | I-518 | |
| Iziphumo ze-WizIntsholongwane kaGawulayo
| Uvavanyo lwesiphumo sokurenta kwakhona | Ireyithi efanelekileyo yexabiso: 96.81% (95% CI 91.03% ~ 98.91%) Ixabiso elibi lokulinganisa: 99.76% (95% CI98.68% ~ 99.96%) Ixabiso elipheleleyo lezinto zokulinganisa: 99.23% (95% CI98.03% ~ 99.70%) | ||
| Ikhanyanisi | Engalunganga | Iyonke | ||
| Iposti | I-91 | 1 | 92 | |
| Engalunganga | 3 | 423 | 446 | |
| Iyonke | I-94 | 424 | I-518 | |
